Compare SCLX & ACFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | ACFN |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | United States | United States |
| Employees | 34 | 27 |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.5M | 40.0M |
| IPO Year | N/A | N/A |
| Metric | SCLX | ACFN |
|---|---|---|
| Price | $5.69 | $16.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 92.6K | 5.6K |
| Earning Date | 04-10-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $122.52 | N/A |
| Revenue Next Year | $186.30 | N/A |
| P/E Ratio | ★ N/A | $6.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.20 | $12.42 |
| 52 Week High | $34.27 | $33.00 |
| Indicator | SCLX | ACFN |
|---|---|---|
| Relative Strength Index (RSI) | 38.04 | 51.06 |
| Support Level | $4.20 | $16.16 |
| Resistance Level | $7.77 | $17.20 |
| Average True Range (ATR) | 0.98 | 0.77 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 1.38 | 74.21 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. The company operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.